Eli Lilly and Company (LLY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
06-2003 | 03-2003 | 12-2002 | 09-2002 | 06-2002 | |
Sales | 3,088,200 | 2,889,400 | 2,955,600 | 2,785,600 | 2,775,200 |
Cost of Goods | 643,000 | 621,300 | 567,800 | 553,700 | 524,900 |
Gross Profit | 2,445,200 | 2,268,100 | 2,387,800 | 2,231,900 | 2,250,300 |
Operating Expenses | 1,585,800 | 1,444,400 | 1,495,900 | 1,422,100 | 1,461,600 |
Operating Income | 859,400 | 824,000 | 892,700 | 810,500 | 789,600 |
Interest Expense | 19,900 | 15,500 | 23,900 | 22,300 | 23,900 |
Other Income | 48,400 | -314,600 | 75,200 | 74,600 | 78,500 |
Pre-tax Income | 887,900 | 493,900 | 944,000 | 862,800 | 844,200 |
Income Tax | 195,700 | 86,900 | 207,700 | 178,900 | 185,700 |
Net Income Continuous | 692,200 | 407,000 | 736,300 | 683,900 | 658,500 |
Net Income | $692,200 | $407,000 | $736,300 | $683,900 | $658,500 |
EPS Basic Total Ops | 0.64 | 0.38 | 0.68 | 0.64 | 0.61 |
EPS Basic Continuous Ops | 0.64 | 0.38 | 0.68 | 0.64 | 0.61 |
EPS Diluted Total Ops | 0.64 | 0.38 | 0.68 | 0.63 | 0.61 |
EPS Diluted Continuous Ops | 0.64 | 0.38 | 0.68 | 0.63 | 0.61 |
EBITDA(a) | $1,003,400 | $968,600 | $992,401 | $941,100 | $920,900 |